Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  1996-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0360-3016(96)00325-2PMID 8892467
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor hypoxia: its impact on cancer therapy

  2004cited by this paper
• Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

  1996cited by this paper
• Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography.

  1995cited by this paper
• A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data.

  1995cited by this paper
• Pretreatment oxygenation profiles of human soft tissue sarcomas.

  1994cited by this paper
• Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors.

  1994cited by this paper
• Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression.

  1994cited by this paper
• Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.

  1993cited by this paper
• The effect of hypoxia on acquired drug resistance and response to epidermal growth factor in chinese hamster lung fibroblasts and human breast‐cancer cells in vitro

  1993cited by this paper
• High-speed automated discrete blood sampling for positron emission tomography.

  1993cited by this paper
• Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix.

  1993cited by this paper
• Oxygenation of head and neck tumors

  1993cited by this paper
• Imaging tumor hypoxia and tumor perfusion.

  1993cited by this paper
• Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole.

  1992cited by this paper
• Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study.

  1992cited by this paper
• Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole.

  1992cited by this paper
• Detection of hypoxic cells in a murine tumor with the use of the comet assay.

  1992cited by this paper
• Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance.

  1991cited by this paper
• Radioiodinated 1-(5-iodo-5-deoxy-beta-D-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): a novel marker of tissue hypoxia.

  1991cited by this paper
• Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements.

  1991cited by this paper
• Oxygenation of carcinomas of the uterine cervix: evaluation by computerized O2 tension measurements.

  1991cited by this paper
• Improving the performance of the SP-3000 PET detector modules

  1991cited by this paper
• Effects of reoxygenation on cells from hypoxic regions of solid tumors: analysis of transplanted murine tumors for evidence of DNA overreplication.

  1990cited by this paper
• Effects of reoxygenation on cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential.

  1990cited by this paper
• Tumor progression: Potential role of unstable genomic changes

  1990cited by this paper
• Effect of transient hypoxia on sensitivity to doxorubicin in human and murine cell lines.

  1990cited by this paper
• Tumor tissue oxygenation as evaluated by computerized-pO2-histography.

  1990cited by this paper
• Characteristics of the binding of labeled fluoromisonidazole in cells in vitro.

  1990cited by this paper
• Tissue distribution of 14C- and 3H-labelled misonidazole in the tumor-bearing mouse.

  1990cited by this paper
• Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules.

  1990cited by this paper
• Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia.

  1989cited by this paper
• A radiosynthesis of fluorine-18 fluoromisonidazole.

  1989cited by this paper
• Correlations between 31P-NMR spectroscopy and tissue O2 tension measurements in a murine fibrosarcoma.

  1989cited by this paper
• Normal fibroblasts responding to anoxia exhibit features of the malignant phenotype.

  1989cited by this paper
• Performance measurements of the SP3000/UW time-of-flight positron emission tomograph

  1988cited by this paper
• Cryospectrophotometric determination of tumor intravascular oxyhemoglobin saturations: dependence on vascular geometry and tumor growth.

  1988cited by this paper
• Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy.

  1988cited by this paper
• Preclinical studies of porfiromycin as an adjunct to radiotherapy.

  1988cited by this paper
• Hypoxia in tumors: a paradigm for the approach to biochemical and physiologic heterogeneity.

  1988cited by this paper
• Frequencies of independent and simultaneous selection of Chinese hamster cells for methotrexate and doxorubicin (adriamycin) resistance.

  1987cited by this paper
• Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells.

  1987cited by this paper
• Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells.

  1986cited by this paper
• Effect of some proliferative and environmental factors on the toxicity of mitomycin C to tumor cells in vitro

  1986cited by this paper
• Oxygen tension in human tumors: in vivo mapping using CT-guided probes.

  1985cited by this paper
• The detection and measurement of hypoxic cells in solid tumors

  1984cited by this paper
• Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells.

  1981cited by this paper
• Intercapillary distance, oxygen tension and local recurrence in cervix cancer.

  1968cited by this paper

• De-escalated Management of HPV-positive Oropharyngeal Carcinoma: Improving Outcomes with Personalized Approaches.

  2025cites this paper
• A Flexible RF Coil Design (OxyTrack) for Oxygen Measurements in Body Cavities

  2025cites this paper
• Lessons Learned in Transforming In Vivo Devices from Pioneering Research into Tools Used Routinely in Medical Diagnostics.

  2025cites this paper
• 68Ga/177Lu-Labeled Bivalent Agents for Targeting Hypoxia and PSMA-Binding in Prostate Cancer.

  2024cites this paper
• Non-FDG hypoxia tracers.

  2024cites this paper
• Biological effectiveness of uniform and nonuniform dose distributions in radiotherapy for tumors with intermediate oxygen levels

  2024cites this paper
• Equivalent uniform aerobic dose in radiotherapy for hypoxic tumors

  2024cites this paper
• Hypoxia-informed RBE-weighted beam orientation optimization for intensity modulated proton therapy.

  2024cites this paper
• A Population-Based Tumor-Volume Model for Head-and-Neck Cancer During Radiotherapy with a Dynamic Oxygenated Compartment.

  2024cites this paper
• Tumor Hypoxia on 18F-fluoromisonidazole Positron Emission Tomography and Distant Metastasis From Head and Neck Squamous Cell Carcinoma

  2024cites this paper
• The significance of partial volume effect on the estimation of hypoxic tumour volume with [18F]FMISO PET/CT

  2024influential citation
• Advances in PET and MRI imaging of tumor hypoxia

  2023cites this paper
• [Research progress on the treatment improvement of HPV-associated oropharyngeal cancer].

  2023cites this paper
• Insight into Tumor Hypoxia: Radionuclide-based Biomarker as Diagnostic Tools.

  2023cites this paper
• Regional 18F-fluoromisonidazole PET images generated from multiple advanced MR images using neural networks in glioblastoma

  2022cites this paper
• FMISO-Based Adaptive Radiotherapy in Head and Neck Cancer

  2022cites this paper
• Timing of hypoxia PET/CT imaging after 18F-fluoromisonidazole injection in non-small cell lung cancer patients

  2022cites this paper
• The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation

  2022cites this paper
• Significance of Specific Oxidoreductases in the Design of Hypoxia-Activated Prodrugs and Fluorescent Turn off–on Probes for Hypoxia Imaging

  2022cites this paper
• Review on Radiation Therapy on Cancer

  2022cites this paper
• Perfusion-Limited Hypoxia Determines the Outcome of Radiation Therapy of Hypoxic Tumours.

  2022cites this paper
• Tumor control probability in hypofractionated radiotherapy as a function of total and hypoxic tumor volumes

  2021cites this paper
• Evaluation of 18F-EF5 for detection of hypoxia in localized adenocarcinoma of the prostate

  2021cites this paper
• Mathematical modeling and analysis of tumor-volume variation during radiotherapy

  2021cites this paper
• 18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: correlation with hypoxia immunohistochemical biomarkers

  2021cites this paper
• Therapeutic Modification of Hypoxia.

  2021cites this paper
• DESIGN, SYNTHESIS, AND BIOLOGICAL TRACING OF 99MTC- DPDQA AS A POTENTIAL MARKER FOR TUMOR IMAGING

  2021cites this paper
• PET Chemistry: Radiopharmaceuticals

  2021cites this paper
• KCa channel blockers increase effectiveness of the EGF receptor TK inhibitor erlotinib in non-small cell lung cancer cells (A549)

  2021cites this paper
• Synthesis and Preliminary Evaluation of a Novel 18F-Labeled 2-Nitroimidazole Derivative for Hypoxia Imaging

  2021influential citation
• HPV‐associated oropharyngeal cancer de‐escalation strategies and trials: Past failures and future promise

  2021cites this paper
• Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation—results from a prospective pilot trial

  2021cites this paper
• PET Imaging in Cardiac Sarcoidosis: A Narrative Review with Focus on Novel PET Tracers

  2021cites this paper
• PET/CT in der Strahlentherapie

  2020cites this paper
• Hypoxia and perfusion in breast cancer: simultaneous assessment using PET/MR imaging

  2020cites this paper
• Radiotherapy Planning and Molecular Imaging in Lung Cancer

  2020cites this paper
• Targeted radiation: Specificity and deescalation

  2020cites this paper
• Dual-Tracer Assessment of Dynamic Changes in Reoxygenation and Proliferation Decrease During Fractionated Radiotherapy in Murine Tumors

  2020cites this paper
• Yttrium-90 Radioembolization and Tumor Hypoxia: Gas-challenge BOLD Imaging in the VX2 Rabbit Model of Hepatocellular Carcinoma.

  2020cites this paper
• Combination therapy and outcomes in head and neck cancer

  2020cites this paper
• Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors

  2020cites this paper
• Volume effects in the TCP for hypoxic and oxygenated tumors.

  2020cites this paper
• Non-FDG PET/CT.

  2020cites this paper
• Hypoxia dynamics on FMISO-PET in combination with PD-1/PD-L1 expression has an impact on the clinical outcome of patients with Head-and-neck Squamous Cell Carcinoma undergoing Chemoradiation

  2020cites this paper
• Tumour functional imaging by PET.

  2020cites this paper
• 18F-HX4/18F-FMISO-based micro PET for imaging of tumor hypoxia and radiotherapy-associated changes in mice.

  2019cites this paper
• Hypoxia Mediates Tumor Malignancy and Therapy Resistance.

  2019cites this paper
• Multivariate Regularized Newton and Levenberg-Marquardt methods: a comparison on synthetic data of tumor hypoxia in a kinetic framework

  2019cites this paper
• Radiation-induced Vascular Damage and the Impact on the Treatment Outcome of Stereotactic Body Radiotherapy

  2019cites this paper
• Functional imaging of cancer using Optoacoustic Tomography

  2019cites this paper
• Data-driven voluntary body motion detection and non-rigid event-by-event correction for static and dynamic PET

  2019cites this paper
• Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials

  2019cites this paper
• Influence of the scan time point when assessing hypoxia in 18F-fluoromisonidazole PET: 2 vs. 4 h

  2019cites this paper
• Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy

  2019cites this paper
• Reoxygenation during radiotherapy in intermediate-risk prostate cancer.

  2019cites this paper
• Correlative analyses between tissue-based hypoxia biomarkers and hypoxia PET imaging in head and neck cancer patients during radiochemotherapy—results from a prospective trial

  2019cites this paper
• Impact of SBRT fractionation in hypoxia dose painting - Accounting for heterogeneous and dynamic tumor oxygenation.

  2019cites this paper
• The role of new PET tracers for lung cancer

  2019cites this paper
• 18F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy.

  2018cites this paper
• Measurement of Tumor Hypoxia in Patients With Locally Advanced Cervical Cancer Using Positron Emission Tomography with 18F-Fluoroazomyin Arabinoside.

  2018cites this paper
• Synthesis and evaluation of an 18 F-labeled trifluoroborate derivative of 2-nitroimidazole for imaging tumor hypoxia with positron emission tomography.

  2018cites this paper
• Modeling of FMISO [F18] nanoparticle PET tracer in normal-cancerous tissue based on real clinical image.

  2018cites this paper
• Pushing the frontiers of radiobiology: a sPecial feature in memory of sir oliver scott and Professor Jack fowler: review article

  2018cites this paper
• To Explore a Representative Hypoxic Parameter to Predict the Treatment Response and Prognosis Obtained by [18F]FMISO-PET in Patients with Non-small Cell Lung Cancer

  2018cites this paper
• Inter-operator variability in compartmental kinetic analysis of 18F-fluoromisonidazole dynamic PET.

  2018cites this paper
• Overview of Positron-Emission Tomography Tracers for Metabolic Imaging

  2018cites this paper
• Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using 18F-fluoromisonidazole PET/CT: a pilot study

  2018cites this paper
• PET Imaging of Cardiac Hypoxia: Hitting Hypoxia Where It Hurts

  2018cites this paper
• Radioiodinated doxorubicin as a new tumor imaging model: preparation, biological evaluation, docking and molecular dynamics

  2018cites this paper
• Hypoxia imaging in upper gastrointestinal tumors and application to radiation therapy.

  2018cites this paper
• High Single Doses of Radiation May Induce Elevated Levels of Hypoxia in Early-Stage Non-Small Cell Lung Cancer Tumors.

  2018cites this paper
• HPV, hypoxia and radiation response in head and neck cancer.

  2018cites this paper
• Volume dependence in hypoxia‐targeted dose escalation

  2018cites this paper
• Optimal timing of fluorine-18-fluoromisonidazole positron emission tomography/computed tomography for assessment of tumor hypoxia in patients with head and neck squamous cell carcinoma

  2018cites this paper
• Investigational PET tracers for high-grade gliomas.

  2018cites this paper
• Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data

  2018cites this paper
• The Effect of Neoadjuvant Androgen Deprivation Therapy on Tumor Hypoxia in High-Grade Prostate Cancer: An 18F-MISO PET-MRI Study.

  2017cites this paper
• Matching the reaction-diffusion simulation to dynamic [18F]FMISO PET measurements in tumors: extension to a flow-limited oxygen-dependent model

  2017cites this paper
• Pulsed Electron Paramagnetic Resonance Imaging: Applications in the Studies of Tumor Physiology

  2017cites this paper
• In Vivo Application of Proton-Electron Double-Resonance Imaging

  2017cites this paper
• Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [18F]Fluoromisonidazole ([18F]FMISO) Kinetic Analysis and Invasive Oxygen Measurements

  2017cites this paper
• Monitoring early response to chemoradiotherapy with 18F-FMISO dynamic PET in head and neck cancer

  2017cites this paper
• Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol

  2017cites this paper
• Clinical overview of the current state and future applications of positron emission tomography in bone and soft tissue sarcoma

  2017cites this paper
• MR-Derived Biomarkers for Cancer Characterization

  2017cites this paper
• Optimal dose and fraction number in SBRT of lung tumours: A radiobiological analysis.

  2017cites this paper
• Components Determination in Hypoxic Glioblastoma Measured with 18F-FMISO PET imaging

  2017cites this paper
• Defining the hypoxic target volume based on positron emission tomography for image guided radiotherapy – the influence of the choice of the reference region and conversion function

  2017cites this paper
• Time, dose and fractionation: accounting for hypoxia in the search for optimal radiotherapy treatment parameters

  2017influential citation
• Tumor Hypoxia and Radiotherapy

  2017cites this paper
• EPR Oximetry of Cetuximab-Treated Head-and-Neck Tumours in a Mouse Model

  2017cites this paper
• [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis

  2017cites this paper
• Theoretical effectiveness of cell survival in fractionated radiotherapy with hypoxia‐targeted dose escalation

  2017cites this paper
• Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [18F]-Fluorodeoxyglucose positron emission tomography radiomics features.

  2017cites this paper
• Molecular mechanisms of hypoxia in cancer

  2017cites this paper
• Data‐driven mapping of hypoxia‐related tumor heterogeneity using DCE‐MRI and OE‐MRI

  2017cites this paper
• Quantitative Analysis of [18F]FMISO PET for Tumor Hypoxia: Correlation of Modeling Results with Immunohistochemistry

  2017cites this paper
• Pharmacokinetic Analysis of Dynamic 18F-Fluoromisonidazole PET Data in Non–Small Cell Lung Cancer

  2017cites this paper
• Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer

  2017cites this paper
• Multiparametric Imaging of Tumor Hypoxia and Perfusion with 18F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer

  2017cites this paper